Moderate-intensity statin combined with ezetimibe versus high-intensity statin monotherapy for secondary cardiovascular risk reduction: a systematic review and meta-analysis
Event: ESC Congress 2024
Topic: Lipid-Lowering Agents
Session: Novel and old treatments, evidence in large populations
